A detailed history of Groupama Asset Managment transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Groupama Asset Managment holds 116,009 shares of BMY stock, worth $6.26 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
116,009
Previous 56,195 106.44%
Holding current value
$6.26 Million
Previous $5.86 Billion 33.39%
% of portfolio
0.05%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $2.41 Million - $3.17 Million
59,814 Added 106.44%
116,009 $3.9 Billion
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $2.31 Million - $2.62 Million
-48,102 Reduced 46.12%
56,195 $5.86 Billion
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $5.06 Million - $6.03 Million
104,297 New
104,297 $5.35 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.